Fresenius Medical Care AG Statistics

Total Valuation

LON:0H9X has a market cap or net worth of GBP 10.73 billion. The enterprise value is 19.84 billion.

Market Cap	10.73B
Enterprise Value	19.84B

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	May 17, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	198.93M

Valuation Ratios

The trailing PE ratio is 19.57.

PE Ratio	19.57
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.40, with an EV/FCF ratio of 15.24.

EV / Earnings	36.19
EV / Sales	1.25
EV / EBITDA	7.40
EV / EBIT	13.70
EV / FCF	15.24

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.76.

Current Ratio	1.37
Quick Ratio	0.79
Debt / Equity	0.76
Debt / EBITDA	3.60
Debt / FCF	7.18
Interest Coverage	3.90

Financial Efficiency

Return on equity (ROE) is 5.82% and return on invested capital (ROIC) is 3.73%.

Return on Equity (ROE)	5.82%
Return on Assets (ROA)	2.98%
Return on Invested Capital (ROIC)	3.73%
Return on Capital Employed (ROCE)	6.11%
Revenue Per Employee	141,579
Profits Per Employee	4,849
Employee Count	119,845
Asset Turnover	0.56
Inventory Turnover	6.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.14% in the last 52 weeks. The beta is 0.86, so LON:0H9X's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+17.14%
50-Day Moving Average	45.30
200-Day Moving Average	39.58
Relative Strength Index (RSI)	37.11
Average Volume (20 Days)	98,917

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0H9X had revenue of GBP 16.01 billion and earned 548.33 million in profits. Earnings per share was 1.87.

Revenue	16.01B
Gross Profit	4.02B
Operating Income	1.35B
Pretax Income	1.02B
Net Income	548.33M
EBITDA	2.01B
EBIT	1.35B
Earnings Per Share (EPS)	1.87

Full Income Statement

Balance Sheet

The company has 1.14 billion in cash and 9.34 billion in debt, giving a net cash position of -8.20 billion.

Cash & Cash Equivalents	1.14B
Total Debt	9.34B
Net Cash	-8.20B
Net Cash Per Share	n/a
Equity (Book Value)	12.31B
Book Value Per Share	38.63
Working Capital	1.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.89 billion and capital expenditures -589.94 million, giving a free cash flow of 1.30 billion.

Operating Cash Flow	1.89B
Capital Expenditures	-589.94M
Free Cash Flow	1.30B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 25.14%, with operating and profit margins of 8.45% and 3.43%.

Gross Margin	25.14%
Operating Margin	8.45%
Pretax Margin	6.35%
Profit Margin	3.43%
EBITDA Margin	12.56%
EBIT Margin	8.45%
FCF Margin	8.13%

Dividends & Yields

This stock pays an annual dividend of 1.02, which amounts to a dividend yield of 2.29%.

Dividend Per Share	1.02
Dividend Yield	2.29%
Dividend Growth (YoY)	4.78%
Years of Dividend Growth	1
Payout Ratio	52.99%
Buyback Yield	0.00%
Shareholder Yield	2.29%
Earnings Yield	5.11%
FCF Yield	12.13%

Dividend Details

Stock Splits

The last stock split was on June 18, 2007. It was a forward split with a ratio of 3.

Last Split Date	Jun 18, 2007
Split Type	Forward
Split Ratio	3

Scores

LON:0H9X has an Altman Z-Score of 1.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	n/a